Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: a brief clinical overview.

D B Strader1, L B Seeff

  • 1Veterans Affairs Medical Center, Washington, D.C. USA.

ILAR Journal
|June 15, 2001
PubMed
Summary

Hepatitis C affects millions globally, often discovered incidentally. Current interferon and ribavirin therapy shows modest results, prompting research into better treatments and vaccines for this public health concern.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.

Alimentary pharmacology & therapeutics·2010
Same author

NIH consensus development statement on management of hepatitis B.

NIH consensus and state-of-the-science statements·2008
Same author

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Journal of viral hepatitis·2008
Same author

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.

Oncogene·2006
Same author

Strategies for assessing the long-term consequences of Hepatitis C virus infection.

Minerva gastroenterologica e dietologica·2006
Same author

The natural history of chronic hepatitis C virus infection.

Clinics in liver disease·2004

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C is a significant global health issue, impacting 170 million people worldwide and 3.9 million Americans.
  • It is a leading cause for liver transplantation and often diagnosed incidentally through routine blood tests.
  • Spontaneous recovery occurs in 20% of cases, while chronic infection can lead to cirrhosis over time.

Purpose of the Study:

  • To summarize the current understanding of Hepatitis C epidemiology and clinical presentation.
  • To review the efficacy and limitations of existing treatments, specifically interferon and ribavirin combination therapy.
  • To highlight ongoing research efforts aimed at improving Hepatitis C management and prevention.

Main Methods:

  • Literature review of epidemiological data on Hepatitis C prevalence.
  • Analysis of clinical outcomes associated with chronic Hepatitis C infection.
  • Overview of current therapeutic strategies, including interferon and ribavirin.
  • Summary of research directions, including treatment optimization, alternative therapies, and vaccine development.

Main Results:

  • Hepatitis C affects millions globally, with diverse progression rates to cirrhosis.
  • Current combination therapy (interferon plus ribavirin) offers modest sustained response rates.
  • Treatment efficacy is lower in certain populations, such as African Americans, and is associated with side effects.

Conclusions:

  • Hepatitis C remains a major public health challenge requiring improved management strategies.
  • Current therapies have limitations, necessitating further research into alternative treatments.
  • Development of effective vaccines and enhanced treatment protocols is crucial for better control of Hepatitis C.

Related Experiment Videos